WO2008109443A3 - Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof - Google Patents
Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof Download PDFInfo
- Publication number
- WO2008109443A3 WO2008109443A3 PCT/US2008/055505 US2008055505W WO2008109443A3 WO 2008109443 A3 WO2008109443 A3 WO 2008109443A3 US 2008055505 W US2008055505 W US 2008055505W WO 2008109443 A3 WO2008109443 A3 WO 2008109443A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cdk2
- nucleic acid
- gene expression
- acid compounds
- cdk2 gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11022—Cyclin-dependent kinase (2.7.11.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present disclosure provides meroduplex ribonucleic acid molecules (mdRNA) capable of decreasing or silencing CDK2 gene expression. An mdRNA of this disclosure comprises at least three strands that combine to form at least two non-overlapping double-stranded regions separated by a nick or gap wherein one strand is complementary to a CDK2 mRNA. In addition, the meroduplex may have at least one uridine is a 5-methyluridine, a nucleoside is a locked nucleic acid, or optionally other modifications, and any combination thereof. Also provided are methods of decreasing expression of a CDK2 gene in a cell or in a subject to treat a CDK2-related disease.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/552,082 US20100105134A1 (en) | 2007-03-02 | 2009-09-01 | Nucleic acid compounds for inhibiting gene expression and uses thereof |
US13/327,545 US20130011922A1 (en) | 2007-03-02 | 2011-12-15 | Nucleic acid compounds for inhibiting gene expression and uses thereof |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93494007P | 2007-03-02 | 2007-03-02 | |
US60/934,940 | 2007-03-02 | ||
US93493007P | 2007-03-16 | 2007-03-16 | |
US60/934,930 | 2007-03-16 | ||
US98691307P | 2007-11-09 | 2007-11-09 | |
US60/986,913 | 2007-11-09 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/055556 Continuation-In-Part WO2008109473A1 (en) | 2007-03-02 | 2008-02-29 | Nucleic acid compounds for inhibiting abcb1 gene expression and uses thereof |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/055340 Continuation-In-Part WO2008109353A1 (en) | 2007-03-02 | 2008-02-28 | Nucleic acid compounds for inhibiting map2k gene expression and uses thereof |
AU2009212920A Division AU2009212920A1 (en) | 2007-03-02 | 2009-09-01 | Nucleic acid compounds for inhibiting gene expression and uses thereof |
US12/552,082 Continuation-In-Part US20100105134A1 (en) | 2007-03-02 | 2009-09-01 | Nucleic acid compounds for inhibiting gene expression and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008109443A2 WO2008109443A2 (en) | 2008-09-12 |
WO2008109443A3 true WO2008109443A3 (en) | 2008-12-11 |
WO2008109443A4 WO2008109443A4 (en) | 2009-02-19 |
Family
ID=39739037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/055505 WO2008109443A2 (en) | 2007-03-02 | 2008-02-29 | Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008109443A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5876637B2 (en) | 2006-10-18 | 2016-03-02 | マリーナ バイオテック,インコーポレイテッド | Nicked or gapped nucleic acid molecules and their use |
WO2012133802A1 (en) | 2011-03-31 | 2012-10-04 | Sbiバイオテック株式会社 | Novel furanone derivative |
EP3100742B1 (en) | 2014-01-31 | 2020-05-20 | Carna Biosciences Inc. | Anticancer agent composition comprising a cdc7 inhibitor and a wee1 inhibitor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007056153A2 (en) * | 2005-11-04 | 2007-05-18 | Nastech Pharmaceutical Company Inc. | Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
WO2007107162A2 (en) * | 2006-03-23 | 2007-09-27 | Santaris Pharma A/S | Small internally segmented interfering rna |
WO2008049078A1 (en) * | 2006-10-18 | 2008-04-24 | Nastech Pharmaceutical Company Inc. | Nicked or gapped nucleic acid molecules and uses thereof |
-
2008
- 2008-02-29 WO PCT/US2008/055505 patent/WO2008109443A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007056153A2 (en) * | 2005-11-04 | 2007-05-18 | Nastech Pharmaceutical Company Inc. | Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
WO2007107162A2 (en) * | 2006-03-23 | 2007-09-27 | Santaris Pharma A/S | Small internally segmented interfering rna |
WO2008049078A1 (en) * | 2006-10-18 | 2008-04-24 | Nastech Pharmaceutical Company Inc. | Nicked or gapped nucleic acid molecules and uses thereof |
Non-Patent Citations (6)
Title |
---|
BRAMSEN JESPER B. ET AL.: "Improved silencing properties using small internally segmented interfering RNAs", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 35, no. 17, 28 July 2007 (2007-07-28), pages 5886 - 5897, XP002458184, ISSN: 0305-1048 * |
HAGERMAN K.R. AND HAGERMAN P.J.: "Helix rigidity of DNA: the meroduplex as an experimental paradigm", JOURNAL OF MOLECULAR BIOLOGY, vol. 260, 1996, pages 207 - 223, XP002484999 * |
LEUSCHNER P J F ET AL: "Cleavage of the siRNA passenger strand during RISC assembly in human cells", EMBO REPORTS, vol. 7, no. 3, 1 March 2006 (2006-03-01), pages 314 - 320, XP002467845 * |
LIN HO ET AL: "Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 28, 9 July 2004 (2004-07-09), pages 29302 - 29307, XP002498333, ISSN: 0021-9258 * |
MILLS JANINE B ET AL: "Origin of the intrinsic rigidity of DNA", NUCLEIC ACIDS RESEARCH,, vol. 32, no. 13, 1 January 2004 (2004-01-01), pages 4055 - 4059, XP002484664 * |
TETSU OSAMU ET AL: "Proliferation of cancer cells despite CDK2 inhibition.", CANCER CELL, vol. 3, no. 3, March 2003 (2003-03-01), pages 233 - 245, XP002498332, ISSN: 1535-6108 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008109443A4 (en) | 2009-02-19 |
WO2008109443A2 (en) | 2008-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008109472A3 (en) | Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof | |
WO2008109381A3 (en) | Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof | |
WO2009029293A3 (en) | Nucleic acid compounds for inhibiting myc gene expression and uses thereof | |
WO2007128477A3 (en) | SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION | |
WO2010017319A3 (en) | Nucleic acid compounds for inhibiting plk1 gene expression and uses thereof | |
WO2008109516A3 (en) | Nucleic acid compounds for inhibiting ras gene expression and uses thereof | |
WO2010006973A3 (en) | Compositions and methods for inhibiting expression of tgf-beta receptor genes | |
WO2008109352A3 (en) | Nucleic acid compounds for inhibiting akt gene expression and uses thereof | |
WO2010017311A3 (en) | Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof | |
WO2007137220A3 (en) | Compositions and methods for inhibiting expression of ikk-b gene | |
WO2008109375A3 (en) | Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof | |
WO2008109469A3 (en) | Nucleic acid compounds for inhibiting pcna gene expression and uses thereof | |
WO2008109350A3 (en) | Nucleic acid compounds for inhibiting il6 gene expression and uses thereof | |
WO2008109548A3 (en) | Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof | |
WO2008109366A3 (en) | Nucleic acid compounds for inhibiting ccnd1 gene expression and uses thereof | |
WO2008109443A3 (en) | Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof | |
WO2008109506A8 (en) | Nucleic acid compounds for inhibiting jun gene expression and uses thereof | |
WO2008109558A3 (en) | Nucleic acid compounds for inhibiting tlr gene expression and uses thereof | |
WO2011139842A3 (en) | Nucleic acid compounds for inhibiting fgfr3 gene expression and uses thereof | |
WO2008109546A3 (en) | Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof | |
WO2008109495A3 (en) | Nucleic acid compounds for inhibiting cd40 gene expression and uses thereof | |
WO2008109487A3 (en) | Nucleic acid compounds for inhibiting mme gene expression and uses thereof | |
WO2008109493A3 (en) | Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof | |
WO2008109364A3 (en) | Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof | |
WO2008109368A3 (en) | Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08731129 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08731129 Country of ref document: EP Kind code of ref document: A2 |